Related Experiment Video
Updated: Aug 5, 2026

14:55
Atomic Scale Structural Studies of Macromolecular Assemblies by Solid-state Nuclear Magnetic Resonance Spectroscopy
Published on: September 17, 2017
Molecular Dynamics Simulations of Aβ42 Dimers with Solid-State NMR Restraints Capture the Key Structural Motifs in
Angelo L Chu1, Betty S L Chu1, Wei Qiang2
1Thomas Jefferson High School for Science and Technology, 6560 Braddock Road, Alexandria, Virginia 22312, United States.
ACS Omega
|August 1, 2026
Summary
Alzheimer's disease (AD) amyloid-beta (Aβ) fibrillation involves specific motifs. Molecular dynamics simulations guided by ssNMR data reveal how Aβ42 peptides fold and form toxic plaques, offering insights into dementia progression.
Area of Science:
- Biochemistry
- Neuroscience
- Computational Biology
Background:
- Alzheimer's disease (AD) is characterized by β-amyloid (Aβ) plaque formation, a primary cause of dementia.
- Understanding the molecular mechanisms of Aβ fibrillation is crucial for developing therapeutic strategies.
Purpose of the Study:
- To explore the conformational evolution and folding of Aβ42 dimers during fibrillation.
- To investigate the role of specific Aβ42 motifs in early-stage nucleation and fibril stabilization.
- To examine the influence of membrane-binding on Aβ oligomer structural pathways.
Main Methods:
- Molecular dynamics (MD) simulations of Aβ42 dimers in solution and membrane-like environments.
- Incorporation of experimental internuclear distance restraints from solid-state nuclear magnetic resonance (ssNMR) spectroscopy to steer simulations.
- Analysis of energy contributions to identify stabilizing motifs in Aβ fibrils.
Main Results:
- Identified key hydrophobic and polar motifs in Aβ42 sequence critical for early fibrillation nucleation.
- These motifs also act as stabilizing agents in mature Aβ fibrils.
- Membrane-binding of small Aβ oligomers was shown to modulate their structural pathways toward fibrillation.
- Revealed molecular-level structural polymorphisms in Aβ42 fibrils.
Conclusions:
- The combination of MD simulations and ssNMR-based restraints provides a reliable method for studying Aβ structural changes.
- Findings enhance the understanding of Aβ42 fibril formation and its role in Alzheimer's disease.
- Insights into Aβ structural polymorphisms may inform future therapeutic interventions for AD.
Related Concept Videos
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

